Tuesday, June 30, 2020

Schrödinger Transforming Drug Discovery with GPU-Powered Platform

Fresh off of a successful IPO earlier this year, Schrödinger has devoted decades to refining computational algorithms to accurately compute important properties of molecules. The company uses NVIDIA GPUs to generate and evaluate petabytes of data to accelerate drug discovery, which is a dramatic improvement over the traditional process of slow and expensive lab work.